Literature DB >> 2069906

Karyotypic evolution in B-cell chronic lymphocytic leukaemia.

D Oscier1, M Fitchett, T Herbert, R Lambert.   

Abstract

Sequential cytogenetic studies were performed on a minimum of two and a maximum of nine occasions (mean 3.6) on the peripheral blood leucocytes of 112 patients with B-CLL. On initial cytogenetic analysis, 58 had a normal karyotype and 64 had a clonal abnormality. Karyotypic evolution occurred in 18 patients (16%). There was no significant difference in the incidence of disease progression between patients with a stable karyotype and those who underwent karyotypic evolution. In only one patient was there a clear association between disease progression, a change in cell morphology and karyotypic evolution.

Entities:  

Mesh:

Year:  1991        PMID: 2069906     DOI: 10.1002/gcc.2870030104

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Authors:  C D Fegan; F E Davies
Journal:  Clin Mol Pathol       Date:  1996-08

2.  Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.

Authors:  Rebeqa Gunnarsson; Larry Mansouri; Anders Isaksson; Hanna Göransson; Nicola Cahill; Mattias Jansson; Markus Rasmussen; Jeanette Lundin; Stefan Norin; Anne Mette Buhl; Karin Ekström Smedby; Henrik Hjalgrim; Karin Karlsson; Jesper Jurlander; Christian Geisler; Gunnar Juliusson; Richard Rosenquist
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

Review 3.  Prognostic factors in chronic lymphocytic leukemia-what do we need to know?

Authors:  Paula Cramer; Michael Hallek
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

4.  Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).

Authors:  Sílvia Beà; Armando López-Guillermo; Maria Ribas; Xavier Puig; Magda Pinyol; Ana Carrió; Lurdes Zamora; Francesc Soler; Francesc Bosch; Stephan Stilgenbauer; Dolors Colomer; Rosa Miró; Emili Montserrat; Elias Campo
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 5.  Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features.

Authors:  Lina van der Straten; Paul J Hengeveld; Arnon P Kater; Anton W Langerak; Mark-David Levin
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

6.  Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.

Authors:  Marc Zapatka; Eugen Tausch; Selcen Öztürk; Deyan Yordanov Yosifov; Martina Seiffert; Thorsten Zenz; Christof Schneider; Johannes Blöhdorn; Hartmut Döhner; Daniel Mertens; Peter Lichter; Stephan Stilgenbauer
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.